Literature DB >> 12072090

Loss of beta-catenin expression is associated with disease progression in malignant melanoma.

J E Osborne.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12072090     DOI： 10.1046/j.1365-2133.2002.47322.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

Review 1.  Melanoma biomarkers: current status and utility in diagnosis, prognosis, and response to therapy.

Authors:  Nikolas K Haass; Keiran S M Smalley
Journal:  Mol Diagn Ther       Date:  2009       Impact factor: 4.074

2.  RTL1 promotes melanoma proliferation by regulating Wnt/β-catenin signalling.

Authors:  Guobiao Fan; Dan Ye; Songcheng Zhu; Jiajie Xi; Xudong Guo; Jing Qiao; Yukang Wu; Wenwen Jia; Guiying Wang; Guohuang Fan; Jiuhong Kang
Journal:  Oncotarget       Date:  2017-11-20

3.  WNT/β-catenin signaling regulates mitochondrial activity to alter the oncogenic potential of melanoma in a PTEN-dependent manner.

Authors:  K Brown; P Yang; D Salvador; R Kulikauskas; H Ruohola-Baker; A M Robitaille; A J Chien; R T Moon; V Sherwood
Journal:  Oncogene       Date:  2017-01-16       Impact factor: 9.867

Review 4.  WNT Signaling in Melanoma.

Authors:  Anna Gajos-Michniewicz; Malgorzata Czyz
Journal:  Int J Mol Sci       Date:  2020-07-09       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.